Legal News

First UPC infringement decision for second medical use claims

Published on: 05 June 2025
Published by a LexisNexis EU Law expert

Table of contents

  • Background
  • The case at hand—Sanofi & Regeneron v Amgen (UPC CFI 505/2024)
  • Validity
  • Infringement
  • Implications for bioscience patents and second medical use claims at the UPC

Article summary

Life Sciences analysis: Chris Weekes, Technical Assistant at D Young & Co, considers a recent landmark decision on the infringement of a second medical use patent, highlighting how the Unified Patent Court (UPC) may treat this type of claim.

Popular documents